L-Thyroxin Aristo

Levothyroxine, the active ingredient in L-Thyroxin Aristo, is a thyroid hormone presented as an oral tablet for systemic use. It replaces deficient thyroid hormone and is prescribed for patients with hypothyroidism, goiter, or as adjuvant therapy in thyroid cancer. The formulation complies with European Union quality standards.

GNH USA supplies L-Thyroxin Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

L‑Thyroxin Aristo (levothyroxine) is used to treat disorders of thyroid hormone deficiency and related conditions.

- Hypothyroidism: restores normal thyroid hormone levels, improving metabolism and symptom control. - Goiter: reduces thyroid‑stimulating hormone stimulation, helping to shrink gland size. - Thyroid cancer (adjuvant therapy): provides hormone replacement after thyroidectomy to suppress TSH and lower recurrence risk.

Levothyroxine may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Headache: mild to moderate headache. - Palpitations: sensation of rapid or irregular heartbeat. - Nervousness or anxiety. - Weight loss: unintended decrease in body weight.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances. - Chest pain: may indicate myocardial ischemia. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Bone loss: accelerated osteoporosis with long‑term overtreatment.

When prescribing or dispensing L‑Thyroxin Aristo, several safety considerations should be observed. - Dose titration: adjust dose based on thyroid function tests and clinical response. - Cardiovascular disease: monitor closely in patients with coronary artery disease or arrhythmias. - Pregnancy and lactation: use only if clearly needed, after risk‑benefit assessment. - Drug interactions: review concomitant medications that may affect levothyroxine absorption or action. - Elderly patients: start with lower doses and monitor for overtreatment. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Levothyroxine can interact with several medicines, altering its absorption or pharmacodynamic effect.

Major Interactions (Avoid): - Calcium or iron supplements: bind levothyroxine in the gut, markedly reducing absorption. - Proton pump inhibitors (e.g., omeprazole): decrease gastric acidity and impair absorption. - Anticonvulsants (phenytoin, carbamazepine): increase metabolism leading to reduced efficacy. - Rifampin: induces hepatic enzymes, lowering serum levothyroxine levels.

Moderate Interactions (Monitor Closely): - Cholestyramine or colestipol: may decrease absorption, requiring dose adjustment. - Warfarin: levothyroxine can enhance anticoagulant effect, necessitating INR monitoring. - Beta‑blockers: may mask symptoms of overtreatment such as tachycardia.